Amoxicillin & Clavulanate Tablets
Beta Lactams · Tablets / Suspension / Injection · 500/125mg (625mg), 875/125mg (1g)
Trade Information
| Minimum Order Qty | 1,000,000 tablets |
| Capacity | 100 Million Tablets per month |
| Strength | 500/125mg (625mg), 875/125mg (1g) |
| Private Labelling | Custom branding, artwork & market-specific labelling |
| Lead Time | 45–60 days from order confirmation |
| Payment Terms | LC at sight, TT (advance / against documents) |
| Shipping | FOB / CIF to major international ports including Mombasa, Dar es Salaam, Lagos, Durban, Manila, Phnom Penh |
| Pharmacopoeia | BP, USP, IP compliant |
Packing Options
- Blister (Alu-Alu / Alu-PVC)
- Strip pack
- Bottle pack (HDPE)
- Hospital bulk pack
- Custom packing as per buyer requirement
Regulatory & Quality
| Registration Status | Registered in multiple African, Asian, and CIS markets. Dossier available for new market registration. |
| Regulatory Dossiers | CTD / ACTD format dossiers available for submission to national drug authorities. |
| Stability Data | Zone IVa & IVb stability data available (tropical climate conditions, 30°C/65% RH & 30°C/75% RH) |
| WHO Prequalification | WHO-GMP Certified |
Product Details
| Composition | Amoxicillin + Clavulanic Acid (as Potassium Clavulanate) |
| Dosage Form | Tablets / Suspension / Injection |
| Pack Size | 10x10, 1x6 / Custom packing available |
| Storage | Store below 25°C in a dry place, protected from light and moisture |
| Shelf Life | 24 months from date of manufacture |
Description
Amoxicillin-Clavulanate (co-amoxiclav) is a broad-spectrum penicillin combination antibiotic that pairs amoxicillin with clavulanic acid, a beta-lactamase inhibitor. It is one of the most widely prescribed antibiotics for infections caused by beta-lactamase-producing bacteria and is listed on the WHO Model List of Essential Medicines.
BioGalen manufactures Amoxicillin-Clavulanate in tablet, paediatric suspension, and injectable forms, supporting both primary-care and hospital procurement across malaria-endemic and broader African markets.
Mechanism of Action
Amoxicillin-Clavulanate combines amoxicillin, a broad-spectrum penicillin that inhibits bacterial cell wall synthesis, with clavulanic acid, a beta-lactamase inhibitor. Many bacteria resist amoxicillin by producing beta-lactamase enzymes that break down the antibiotic. Clavulanic acid binds and inactivates these enzymes, protecting amoxicillin and restoring its activity against beta-lactamase-producing organisms. The combination therefore covers a broader spectrum than amoxicillin alone, including many resistant strains encountered in respiratory, urinary, and skin infections.
Indications
- Respiratory tract infections
- Ear, nose, and throat infections
- Urinary tract infections
- Skin and soft tissue infections
- Dental infections
Available Variants
- Amoxicillin 500mg & Clavulanate 125mg Tablets
- Amoxicillin 875mg & Clavulanate 125mg Tablets
- Amoxicillin & Clavulanate Oral Suspension
- Amoxicillin & Clavulanate Injection
Frequently Asked Questions
What is Amoxicillin-Clavulanate used for?
What forms of Amoxicillin-Clavulanate does BioGalen manufacture?
Does BioGalen supply Amoxicillin-Clavulanate for hospital tenders?
Related Products
Interested in Amoxicillin & Clavulanate Tablets?
Get competitive pricing for bulk orders, private labelling, and contract manufacturing.
Browse Categories
Browse by Dosage Form
Product Enquiry
Fill in your details and we'll get back to you within 30 minutes.
Enquiry Sent!
Our team will review your requirements and respond within 30 minutes.